Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Ameresco Q4 Profit Edges Up - Quick Facts

Ameresco Inc. (AMRC: Quote) announced Wednesday a higher fourth-quarter profit of $8.2 million, or $0.18 per share, compared to the prior-year's $7.7 million, or $0.17 per share. Seven analysts polled by Thomson Reuters estimated earnings of $0.19 per share. Analysts' estimates usually exclude special items.

Quarterly revenue went up 5.1 percent to $188.5 million from last year's $179.3 million, thanks to Renewable Energy revenue rising to $55.9 million from $47.6 million. Energy efficiency revenue was $132.6 million this year and $131.8 million a year ago. Six analysts polled by Thomson Reuters estimated revenues of $185.72 million.

Looking ahead, the company forecast 2012 profit between $39.5 million and $42.5 million, on revenues in the range of $800 million to $825 million. Analysts' consensus currently sees 2012 revenues of $793.79 million.

Click here to receive FREE breaking news email alerts for Ameresco Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After trending higher over the past several sessions, stocks showed a lack of direction throughout the trading day on Friday before closing roughly flat. A muted reaction to a highly anticipated speech by Federal Reserve Chair Janet Yellen contributed to the lackluster performance. Republican Scott Brown has significantly narrowed the gap in the race against incumbent New Hampshire Sen. Jeanne Shaheen, D-N.H., according to the results of a new WMUR Granite State Poll. On the heels of the violent clashes between local police and protestors in Ferguson, Missouri, Sen. Claire McCaskill, D-Mo., announced that she will hold a Senate hearing in September to examine the militarization of local police departments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.